PVLA Competitors & Alternatives
Compare Palvella Therapeutics, Inc with similar stocks in the same industry
Biotechnology
PVLA
Main Stock$146.76
Tradestie Score
59
Market Cap
$699.30M
Analyst Upside
+56.4%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.83
|
$2.18B | - | 61 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.38
|
$2.08B | - | 50 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$19.28
|
$2.02B | 54.0 | 56 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$17.56
|
$2.01B | - | 55 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.69
|
$1.97B | - | 63 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.64
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$107.95
|
$1.92B | - | 55 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$78.93
|
$1.90B | 466.6 | 55 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$41.20
|
$1.84B | - | 59 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.50
|
$1.81B | - | 64 | Compare |
More PVLA Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry